Filing search / Viking Therapeutics, Inc. / "Retirement"

S-8

EX-4.2

VKTX Viking Therapeutics, Inc.

22 May 24

Registration of securities for employees

4:33pm

or substituted, (iii) a Change in Control, or (iv) such Participant’s retirement (as such term may be defined in the Award Agreement or another applicable

8-K

EX-1.1

VKTX Viking Therapeutics, Inc.

1 Mar 24

Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock

4:05pm

the minimum funding standards of Section 302 of the United States Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and the regulations … in the “accumulated post-retirement benefit obligations” (within the meaning of Statement of Financial Accounting Standards 106) of the Company and its

S-3ASR

EX-4.2

VKTX Viking Therapeutics, Inc.

26 Jul 23

Automatic shelf registration

5:26pm

be applicable to any sinking fund for the retirement of the Securities of a Series, except as otherwise permitted or required by any form of Security

PRE 14A

r7qj 895aw

17 Apr 23

Preliminary proxy

5:04pm

8-K

EX-1.1

r5f2alrsw62aj 8z973

31 Mar 23

Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock

5:27pm

8-K

EX-1.1

tdksz114 ajs8tr

21 Sep 18

Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock

6:05am

8-K

EX-1.1

dmr5l5o3r3

7 Jun 18

Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock

1:41pm

424B4

2wvdn5iqu0bohsgxm

8 Apr 16

Prospectus supplement with pricing info

12:00am